| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Marylanders spent a record $96.5 million on cannabis products in December, reported Marijuana Moment citing data published by the Maryland Cannabis Administration (MCA).
Out of that sum, recreational cannabis sales accounted for $61.5 million, while medical marijuana totaled roughly $35 million for the month.
Maryland has been reporting record sales since the recreational market launch this past summer. At the time, existing cannabis companies that operated in Maryland, such as Curaleaf Holdings Inc. (CSE:CURA) (OTC:CURLF), Green Thumb Industries Inc. (OTCQX:GTBIF) (CSE:GTII), Verano Holdings Corp. (CSE:VRNO) (OTCQX:VRNOF) and Cresco Labs Inc (OTC:CRLBF), to name a few, made the switch to adult-use shops by paying a one-time fee of 8% of their gross 2022 dispensary revenue (not to exceed $2 million).
In just the first seven days after legal cannabis sales got underway on July 1, licensed shops raked in $20.9 million in weed products and they’ve been going strong ever since.
In total, Maryland recorded $787.5 million in sales of legalized marijuana products combined in 2023.
Over the same period Rhode Islanders spent over $107.8 million on combined cannabis sales, writes Marijuana Moment, citing data from the state's Department of Business Regulation (DBR).
Now read: Holiday High: Tracking End-of-Year Cannabis Sales in Maine, Rhode Island And Canada
On a monthly basis, December saw record-breaking sales of recreational marijuana, as purchases soared to $7.8 million, while medical cannabis sales amounted to $2.4 million for the period.
Marijuana edibles, raw prerolls, vape carts, and prepackaged cannabis flower were all in high demand in December when it came to sales by product type, while consumers cut back on purchases of concentrates, infused prerolls and tinctures, DBT data showed.
Did you miss the first wave of cannabis investments? Don't make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
But here's the kicker: Michael is about to release his next potential winners, and he's chomping at the bit to share these ticker symbols with you ASAP.
Don't miss out on the green rush!
Posted In: CRLBF CSE:CURA CSE:GTII CSE:VRNO CURLF GTBIF GTII VRNOF
